Israel A, Gat R, Oster H, Moshe Y, Raz I, Mittelman M, Merzon E. Diabetes mellitus and diabetes-related complications are common in patients with myelodysplastic syndromes but Hemoglobin A1C is an inadequate marker. haematol [Internet]. 2026Jul.1 [cited 2026Jul.28];111(7):2504-7. Available from: https://haematologica.org/article/view/13131